Spinnaker Trust Sells 195 Shares of Agilent Technologies, Inc. (NYSE:A)

Spinnaker Trust decreased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 7.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,544 shares of the medical research company’s stock after selling 195 shares during the period. Spinnaker Trust’s holdings in Agilent Technologies were worth $354,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. OFI Invest Asset Management bought a new position in shares of Agilent Technologies in the third quarter worth about $25,000. MV Capital Management Inc. lifted its stake in Agilent Technologies by 120.7% in the fourth quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock worth $27,000 after acquiring an additional 105 shares during the period. Baystate Wealth Management LLC lifted its stake in Agilent Technologies by 107.3% in the fourth quarter. Baystate Wealth Management LLC now owns 257 shares of the medical research company’s stock worth $36,000 after acquiring an additional 133 shares during the period. Column Capital Advisors LLC lifted its stake in Agilent Technologies by 1,111.1% in the third quarter. Column Capital Advisors LLC now owns 327 shares of the medical research company’s stock worth $37,000 after acquiring an additional 300 shares during the period. Finally, Rosenberg Matthew Hamilton lifted its stake in Agilent Technologies by 51.1% in the fourth quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock worth $39,000 after acquiring an additional 96 shares during the period.

Insider Buying and Selling

In related news, SVP Philip Binns sold 2,827 shares of the business’s stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $147.54, for a total transaction of $417,095.58. Following the completion of the sale, the senior vice president now owns 9,997 shares in the company, valued at $1,474,957.38. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, CEO Michael R. Mcmullen sold 52,297 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $150.00, for a total transaction of $7,844,550.00. Following the completion of the sale, the chief executive officer now owns 253,909 shares in the company, valued at $38,086,350. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Philip Binns sold 2,827 shares of the company’s stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $147.54, for a total value of $417,095.58. Following the sale, the senior vice president now owns 9,997 shares of the company’s stock, valued at approximately $1,474,957.38. The disclosure for this sale can be found here. Insiders sold a total of 61,610 shares of company stock worth $9,220,333 over the last 90 days.

Wall Street Analysts Forecast Growth

Several analysts have commented on A shares. Barclays increased their price target on shares of Agilent Technologies from $125.00 to $135.00 and gave the company an “underweight” rating in a research report on Wednesday, April 10th. Evercore ISI increased their price objective on shares of Agilent Technologies from $132.00 to $145.00 and gave the company an “in-line” rating in a research report on Thursday, April 4th. Oppenheimer increased their price objective on shares of Agilent Technologies from $67.00 to $90.00 and gave the company an “outperform” rating in a research report on Tuesday, March 26th. UBS Group increased their price target on shares of Agilent Technologies from $130.00 to $155.00 and gave the stock a “neutral” rating in a report on Wednesday, February 28th. Finally, Citigroup increased their price target on shares of Agilent Technologies from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, February 28th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $141.29.

Agilent Technologies Trading Up 1.0 %

Shares of NYSE A traded up $1.37 during trading on Friday, hitting $137.74. 754,945 shares of the company were exchanged, compared to its average volume of 1,245,651. The company has a fifty day moving average price of $141.59 and a 200-day moving average price of $130.56. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.04 and a current ratio of 2.68. The firm has a market capitalization of $40.36 billion, a PE ratio of 32.78, a P/E/G ratio of 4.13 and a beta of 1.11. Agilent Technologies, Inc. has a 12-month low of $96.80 and a 12-month high of $151.58.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Tuesday, February 27th. The medical research company reported $1.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.07. The firm had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.59 billion. Agilent Technologies had a return on equity of 27.09% and a net margin of 18.35%. The company’s quarterly revenue was down 5.5% on a year-over-year basis. During the same period last year, the company earned $1.37 EPS. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 5.5 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 24th. Stockholders of record on Tuesday, April 2nd were given a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date was Monday, April 1st. Agilent Technologies’s dividend payout ratio is presently 22.38%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.